Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zynerba Pharma CS (NQ: ZYNE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zynerba Pharma CS < Previous 1 2 3 4 5 6 7 8 9 10 Next > Psychedelic & Marijuana Drug Stocks Continue To Decline February 27, 2022 This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE... Via Talk Markets Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week February 21, 2022 An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt Via Talk Markets Cannabis Movers & Shakers: Cresco, Agricor & Botanacor, C3 Industries, Akanda, CULTA, OWP, Zynerba February 17, 2022 Cresco Labs Taps Megan Kulick To Serve As VP Of Investor Relations Cresco Labs (OTC: Via Benzinga Psychedelic Stocks Finally In An Upswing February 06, 2022 The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week. Via Talk Markets Cannabis Stock Gainers And Losers From January 31, 2022 January 31, 2022 GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 Via Benzinga The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January January 30, 2022 This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. Via Talk Markets Cannabis Stock Gainers And Losers From January 28, 2022 January 28, 2022 GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33 Via Benzinga Cannabis Stock Gainers And Losers From January 26, 2022 January 26, 2022 GAINERS: Item 9 Labs (OTC: Via Benzinga Cannabis Stock Gainers And Losers From January 24, 2022 January 24, 2022 GAINERS: Leviathan Natural Prods (OTC: Via Benzinga Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD January 23, 2022 This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a... Via Talk Markets Cannabis Stock Gainers And Losers From January 18, 2022 January 18, 2022 GAINERS: Item 9 Labs (OTC: Via Benzinga Marijuana & Psychedelic Drug Stocks Continue To Decline January 16, 2022 The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are... Via Talk Markets Cannabis Stock Gainers And Losers From January 14, 2022 January 14, 2022 GAINERS: Cannabix Technologies (OTC: Via Benzinga Cannabis Stock Gainers And Losers From January 13, 2022 January 13, 2022 GAINERS: MGC Pharmaceuticals (OTC: Via Benzinga Cannabis Stock Gainers And Losers From January 12, 2022 January 12, 2022 GAINERS: Cannabix Technologies (OTC: Via Benzinga Stocks That Hit 52-Week Lows On Friday January 14, 2022 During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... Via Benzinga Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High January 09, 2022 There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents. Via Talk Markets Stocks That Hit 52-Week Lows On Thursday January 06, 2022 On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... Via Benzinga Cannabis Stock Gainers And Losers From January 5, 2022 January 05, 2022 GAINERS: Rhinomed (OTC: Via Benzinga Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC January 05, 2022 The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ... Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets January 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,... Via Benzinga Zynerba Discontinues Development Of Cannabidiol Gel In Epileptic Disorders January 05, 2022 Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) has decided not to advance Zygel against developmental and epileptic encephalopathies (DEE). The decision was in line... Via Benzinga Cannabis Stock Gainers And Losers From January 3, 2022 January 03, 2022 GAINERS: BioHarvest Sciences (OTC: Via Benzinga Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD December 17, 2021 A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index. Via Talk Markets Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November December 01, 2021 A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. Via Talk Markets Topics Cannabis Exposures Cannabis $UBER Jumps into Canadian Cannabis; NASDAQ Issues MCTO to $CRON — Cannabis Daily November 22, 2021 November 22, 2021 The Best Daily Overview Of The Cannabis Space Uber enters into cannabis space in Ontario, Canada by listing Tokyo Smoke in its ma... Via Benzinga Topics Cannabis Exposures Cannabis The Biotech Stock Numbers You Need to Know October 11, 2021 Biotech investing is different from other kinds of investing because biotech is pretty much the only sector in which companies go public before they have a product to sell. Let's take a look at Zynerba... Via Talk Markets September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances October 01, 2021 Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? Via Talk Markets Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September September 20, 2021 Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? Via Talk Markets Topics Cannabis Exposures Cannabis Zynerba Stock Moves Higher On Long-Term Zygel Data In Autistic Children September 09, 2021 Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) presented data from the Phase 2 BRIGHT trial of Zygel in children and adolescents with autism spectrum disorder (ASD) over a... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
